Cargando…
Tumor microenvironment-responsive fenton nanocatalysts for intensified anticancer treatment
Chemodynamic therapy (CDT) based on Fenton or Fenton-like reactions is an emerging cancer treatment that can both effectively fight cancer and reduce side effects on normal cells and tissues, and it has made important progress in cancer treatment. The catalytic efficiency of Fenton nanocatalysts(F-N...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8817594/ https://www.ncbi.nlm.nih.gov/pubmed/35123493 http://dx.doi.org/10.1186/s12951-022-01278-z |
_version_ | 1784645680412753920 |
---|---|
author | Wang, Yandong Gao, Fucheng Li, Xiaofeng Niu, Guiming Yang, Yufei Li, Hui Jiang, Yanyan |
author_facet | Wang, Yandong Gao, Fucheng Li, Xiaofeng Niu, Guiming Yang, Yufei Li, Hui Jiang, Yanyan |
author_sort | Wang, Yandong |
collection | PubMed |
description | Chemodynamic therapy (CDT) based on Fenton or Fenton-like reactions is an emerging cancer treatment that can both effectively fight cancer and reduce side effects on normal cells and tissues, and it has made important progress in cancer treatment. The catalytic efficiency of Fenton nanocatalysts(F-NCs) directly determines the anticancer effect of CDT. To learn more about this new type of therapy, this review summarizes the recent development of F-NCs that are responsive to tumor microenvironment (TME), and detailedly introduces their material design and action mechanism. Based on the deficiencies of them, some effective strategies to significantly improve the anticancer efficacy of F-NCs are highlighted, which mainly includes increasing the temperature and hydrogen peroxide concentration, reducing the pH, glutathione (GSH) content, and the dependence of F-NCs on acidic environment in the TME. It also discusses the differences between the effect of multi-mode therapy with external energy (light and ultrasound) and the single-mode therapy of CDT. Finally, the challenges encountered in the treatment process, the future development direction of F-NCs, and some suggestions are analyzed to promote CDT to enter the clinical stage in the near future. GRAPHICAL ABSTRACT: [Image: see text] SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12951-022-01278-z. |
format | Online Article Text |
id | pubmed-8817594 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-88175942022-02-07 Tumor microenvironment-responsive fenton nanocatalysts for intensified anticancer treatment Wang, Yandong Gao, Fucheng Li, Xiaofeng Niu, Guiming Yang, Yufei Li, Hui Jiang, Yanyan J Nanobiotechnology Review Chemodynamic therapy (CDT) based on Fenton or Fenton-like reactions is an emerging cancer treatment that can both effectively fight cancer and reduce side effects on normal cells and tissues, and it has made important progress in cancer treatment. The catalytic efficiency of Fenton nanocatalysts(F-NCs) directly determines the anticancer effect of CDT. To learn more about this new type of therapy, this review summarizes the recent development of F-NCs that are responsive to tumor microenvironment (TME), and detailedly introduces their material design and action mechanism. Based on the deficiencies of them, some effective strategies to significantly improve the anticancer efficacy of F-NCs are highlighted, which mainly includes increasing the temperature and hydrogen peroxide concentration, reducing the pH, glutathione (GSH) content, and the dependence of F-NCs on acidic environment in the TME. It also discusses the differences between the effect of multi-mode therapy with external energy (light and ultrasound) and the single-mode therapy of CDT. Finally, the challenges encountered in the treatment process, the future development direction of F-NCs, and some suggestions are analyzed to promote CDT to enter the clinical stage in the near future. GRAPHICAL ABSTRACT: [Image: see text] SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12951-022-01278-z. BioMed Central 2022-02-05 /pmc/articles/PMC8817594/ /pubmed/35123493 http://dx.doi.org/10.1186/s12951-022-01278-z Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Review Wang, Yandong Gao, Fucheng Li, Xiaofeng Niu, Guiming Yang, Yufei Li, Hui Jiang, Yanyan Tumor microenvironment-responsive fenton nanocatalysts for intensified anticancer treatment |
title | Tumor microenvironment-responsive fenton nanocatalysts for intensified anticancer treatment |
title_full | Tumor microenvironment-responsive fenton nanocatalysts for intensified anticancer treatment |
title_fullStr | Tumor microenvironment-responsive fenton nanocatalysts for intensified anticancer treatment |
title_full_unstemmed | Tumor microenvironment-responsive fenton nanocatalysts for intensified anticancer treatment |
title_short | Tumor microenvironment-responsive fenton nanocatalysts for intensified anticancer treatment |
title_sort | tumor microenvironment-responsive fenton nanocatalysts for intensified anticancer treatment |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8817594/ https://www.ncbi.nlm.nih.gov/pubmed/35123493 http://dx.doi.org/10.1186/s12951-022-01278-z |
work_keys_str_mv | AT wangyandong tumormicroenvironmentresponsivefentonnanocatalystsforintensifiedanticancertreatment AT gaofucheng tumormicroenvironmentresponsivefentonnanocatalystsforintensifiedanticancertreatment AT lixiaofeng tumormicroenvironmentresponsivefentonnanocatalystsforintensifiedanticancertreatment AT niuguiming tumormicroenvironmentresponsivefentonnanocatalystsforintensifiedanticancertreatment AT yangyufei tumormicroenvironmentresponsivefentonnanocatalystsforintensifiedanticancertreatment AT lihui tumormicroenvironmentresponsivefentonnanocatalystsforintensifiedanticancertreatment AT jiangyanyan tumormicroenvironmentresponsivefentonnanocatalystsforintensifiedanticancertreatment |